Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma
出版年份 2012 全文链接
标题
Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma
作者
关键词
-
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume 19, Issue 8, Pages 2744-2752
出版商
Springer Nature
发表日期
2012-01-18
DOI
10.1245/s10434-011-2188-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma
- (2011) Yu-Jia Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Survivin-Mediated Cancer Cell Migration Through GRP78 and Epithelial-Mesenchymal Transition (EMT) Marker Expression in Mahlavu Cells
- (2011) Cheng-Jeng Tai et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
- (2011) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
- (2011) Brian R. Sloat et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
- (2011) R. A. Carrasco et al. MOLECULAR CANCER THERAPEUTICS
- Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
- (2010) Yu-Jia Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Knockdown of Thrombomodulin Enhances HCC Cell Migration through Increase of ZEB1 and Decrease of E-cadherin Gene Expression
- (2010) Ming-Te Huang et al. ANNALS OF SURGICAL ONCOLOGY
- Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma
- (2010) Giuseppe Lombardi et al. CANCER
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
- (2010) R. S. Finn CLINICAL CANCER RESEARCH
- Targeting survivin in cancer: patent review
- (2010) Jagat R Kanwar et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity
- (2009) J. Shen et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma
- (2009) Jeng-Fong Chiou et al. ANNALS OF SURGICAL ONCOLOGY
- Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
- (2009) Pepita Gimenez-Bonafe et al. CURRENT CANCER DRUG TARGETS
- Clinical pharmacology and pharmacogenetics of gemcitabine
- (2009) Andrea Wong et al. DRUG METABOLISM REVIEWS
- Molecular targeted therapy for hepatocellular carcinoma
- (2009) Melanie Thomas JOURNAL OF GASTROENTEROLOGY
- Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
- (2009) Liang Li et al. PLoS One
- Systemic therapy of hepatocellular carcinoma: Are we making progress?
- (2008) Patricia Roxburgh et al. ADVANCES IN THERAPY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma
- (2008) Amani Asnacios et al. CANCER
- Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission
- (2008) Stefanie Sowinski et al. NATURE CELL BIOLOGY
- Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors
- (2008) Romano Danesi et al. PHARMACOGENOMICS
- Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
- (2008) S.-K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now